Showing results (51-60 of 1,842) with videos related to
Sort By:
Pageof 185
Journal of Immunology (Baltimore, Md. : 1950)|March 1, 1983
Correlation between differentiation, expression of monocyte-specific antigens, and cytotoxic functions in human promyelocytic cell lines treated with leukocyte-conditioned mediumE T Dayton, B Perussia, G TrinchieriJournal of Immunology (Baltimore, Md. : 1950)|August 1, 1978
Cell-mediated cytotoxicity against virus-infected target cells in humans. I. Characterization of the effector lymphocyteD Santoli, G Trinchieri, F S LiefClinical Immunology (Orlando, Fla.)|January 6, 2001
Modulation of susceptibility and resistance to an autoimmune model of multiple sclerosis in prototypically susceptible and resistant strains by neutralization of interleukin-12 and interleukin-4, respectivelyC S Constantinescu, B Hilliard, E Ventura, et al.European Cytokine Network|November 27, 1998
Positive and negative regulation of interleukin-12 gene expressionX Ma, H Riemann, G Gri, et al.Current Topics in Microbiology and Immunology|December 6, 2005
Dendritic cell-NK cell cross-talk: regulation and physiopathologyL Zitvogel, M Terme, C Borg, et al.The Journal of Experimental Medicine|May 1, 1985
Inhibition of bone marrow colony formation by human natural killer cells and by natural killer cell-derived colony-inhibiting activityG Degliantoni, B Perussia, L Mangoni, et al.Journal of Virology|December 1, 1995
The in vivo antiviral activity of interleukin-12 is mediated by gamma interferonL Ozmen, M Aguet, G Trinchieri, et al.The Journal of Experimental Medicine|July 1, 1986
Gamma interferon and lymphotoxin, released by activated T cells, synergize to inhibit granulocyte/monocyte colony formationM Murphy, R Loudon, M Kobayashi, et al.The Journal of Biological Chemistry|April 18, 1997
Identification and characterization of a novel Ets-2-related nuclear complex implicated in the activation of the human interleukin-12 p40 gene promoterX Ma, M Neurath, G Gri, et al.Cancer Gene Therapy|October 10, 2009
Improved nonviral cancer suicide gene therapy using survivin promoter-driven mutant BaxH Garg, R Salcedo, G Trinchieri, et al.Pageof 185